Xie Jian 4

What Happened
Xie Jian, President and COO of Fulgent Genetics (FLGT), sold 2,146 shares on June 2, 2026, for total proceeds of $38,382. The reported weighted-average sale price was $17.89. The filing states the shares were sold to satisfy tax withholding obligations arising from the vesting of restricted stock units granted February 25, 2025.

Key Details

• Transaction date: 2026-06-02; filing date: 2026-06-03 (filed next day, appears timely).
• Sale type/code: Open market/private sale (S).
• Shares sold: 2,146; weighted-average price: $17.89; total proceeds: $38,382.
• Price range: sales executed in multiple transactions at $17.63–$18.10; reported price is the weighted average. Reporting person offered to provide per-transaction details on request.
• Reason per footnote: sale to satisfy tax withholding on vested RSUs (grant originally reported 2025-02-27).
• Shares owned after transaction: not disclosed on this Form 4.
• Additional note: footnote indicates certain securities are held by The Hsieh Family Dynasty Trust; Mr. Xie serves on its investment committee and disclaims beneficial interest except for any pecuniary interest.

Context
This appears to be a routine tax-withholding sale tied to RSU vesting rather than an independent directional trade. Such withholding sales are common and do not necessarily indicate the insider’s view on the company’s outlook.